Clinical Trials Directory

Trials / Completed

CompletedNCT01698294

Biomarkers in Post-Menopausal Women Receiving Flaxseed

A Pilot Study of the Flaxseed Effects on Hormones and Lignans: Role of Race, Genes, and Gut Microbiome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
258 (actual)
Sponsor
Roswell Park Cancer Institute · Academic / Other
Sex
Female
Age
45 Years – 80 Years
Healthy volunteers
Accepted

Summary

This randomized clinical trial studies biomarkers in post-menopausal women receiving flaxseed. Studying samples of blood, urine, and feces in the laboratory from participants receiving flaxseed may help doctors understand the effects of flaxseed on biomarkers.

Detailed description

PRIMARY OBJECTIVES: I. To determine associations between the composition of the gut bacterial communities and baseline levels of the mammalian lignans and steroid hormones. II. To determine how variation in gut microbial community composition and in steroid hormone and xenobiotic metabolizing genes affects the metabolism of mammalian lignans and steroid hormones after exposure to a lignan-rich food (flaxseed). III. To determine how these associations differ by race (i.e., African American and European American women). OUTLINE: Participants are randomized to 1 of 2 treatment groups. GROUP I: Participants receive flaxseed orally (PO) daily for 6 weeks. After a usual diet "washout" period of 8 weeks, patients crossover to Group II. GROUP II: Participants maintain a usual diet for 6 weeks. After a usual diet "washout" period of 8 weeks, patients crossover to Group I. After completion of study treatment, participants are followed up for 30 days.

Conditions

Interventions

TypeNameDescription
OTHERClinical ObservationParticipants maintain usual diet and undergo clinical observation
DIETARY_SUPPLEMENTFlaxseedGiven PO
OTHERLaboratory Biomarker AnalysisCorrelative studies
OTHERQuestionnaire AdministrationAncillary studies

Timeline

Start date
2012-12-14
Primary completion
2017-06-08
Completion
2017-06-08
First posted
2012-10-02
Last updated
2022-05-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01698294. Inclusion in this directory is not an endorsement.